Indication
Alzheimer disease
2 clinical trials
4 products
Product
[18F]GTP1Clinical trial
Phase 1 Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's DiseaseStatus: Completed, Estimated PCD: 2023-06-27
Product
[18F]PI-2620Product
[18F]MK-6240Clinical trial
A Randomized, Participant & Investigator Blinded, Placebo-Controlled Study to Evaluate the Ability of Intrathecally Administered NIO752 to Lower CSF Total Tau Synthesis in Participants With AD Measured by Stable Isotope Labelling KineticsStatus: Not yet recruiting, Estimated PCD: 2025-02-01
Product
NIO752